Informa Pharma Intelligence and goBalto Partner to Enrich Clinical Trial Data for Clients
(Thomson Reuters ONE) -
Citeline, powered by Informa Pharma Intelligence, is being integrated with
goBalto's Select to provide broader knowledge of clinical trials and
investigators in order to optimize the site selection process
NEW YORK, June 19, 2017 (GLOBE NEWSWIRE) -- Today, Citeline, the gold standard
in drug, trial and clinical investigator intelligence, powered by Informa
Pharma's Business Intelligence, and goBalto, the industry-leader in cloud-based
clinical study startup solutions, are announcing a partnership to integrate data
from Citeline's Trialtrove and Sitetrove solutions into goBalto's Select, for
optimizing site selection and accelerating clinical trial success.
By incorporating intelligence from Citeline, mutual goBalto and Citeline clients
can access the most comprehensive collection of global clinical trials, clinical
trial investigator profiles and drug development pipelines. By directly
including Citeline data with client's internal assets in goBalto Select and
other third-party databases, companies can realize a more robust, data-driven
approach to accelerate the startup phases of clinical trials and optimize site
selection - all in a single platform solution.
Trialtrove provides the industry's most robust coverage of the global clinical
trial landscape and is the most comprehensive source for the complete history of
individual clinical trials, while Sitetrove offers access to nearly 400,000
clinical investigators and 150,000 trial sites to help greatly improve clinical
trial success. goBalto's award-winning Select offers a data-driven approach by
weighing selection and performance variables to reduce the risks of selecting
non-active, non-enrolling (NANE) sites and target populations ideally suited to
studies in clinical trials. goBalto and Citeline client's will greatly benefit
from the increased depth and breadth of data available to them allowing for
faster and more accurate site selection decisions.
Jason Tse, Head of Strategic Partnerships at Pharma Intelligence said, "We're
excited to team up with goBalto, knowing that our clients will benefit from
their clinical trial operational expertise. Additionally, the partnership with
goBalto further emphasizes our strategy to drive value and growth for our
clients through strategic partnerships. Providing access to our data and
insights through goBalto's platform helps expand knowledge of clinical trials
and clinical investigator/site history to help achieve better results. Research
and decisions in clinical trials can be made easier, faster and better through
this partnership."
Sujay Jadhav, CEO of goBalto explained, "Informa Pharma Intelligence has a
robust trove of data and deep understanding of clinical trials that our
customers will find extremely valuable. Our partnership will speed up clinical
trials and get much needed therapies to patients faster."
This partnership is kicking off ahead of the Drug Information Association (DIA)
2017 Annual Meeting taking place in Chicago on June 18. Both Informa Pharma
Intelligence and goBalto will be attending the event at booth #'s 1148 and
1854, respectively. If you are interested in speaking with Informa Pharma
Intelligence and goBalto at DIA please reach out to Robert.schraf(at)informa.com.
About Citeline
Citeline, part of Informa's Pharma Intelligence vertical, is the world's most
comprehensive source of real-time R&D intelligence for the pharmaceutical
industry, featuring an unmatched intelligence collection and enrichment of
global clinical trials, clinical trial investigator profiles and drug
development pipelines.
Citeline is the R&D Intelligence arm of Informa's Pharma Intelligence vertical,
one of the world's leading providers of drug, device, company, clinical trial
and market intelligence in the pharma and medtech markets. For more
information, visit https://pharmaintelligence.informa.com/
About goBalto
goBalto is the industry leader in cloud-based study startup software for the
global life sciences industry, offering the only complete end-to-end platform
for starting clinical trials, from site identification, feasibility assessment
and selection through to activation, with comprehensive metrics to track
adherence to timelines and budget. Committed to accelerating clinical trials
through innovation, product excellence, and customer success, goBalto works with
three of the top five CROs and more than two-thirds of the top 25 pharmas. Our
customers include: Allergan, Covance, CMIC HOLDINGS, Genentech Roche, ICON, INC
Research, Novartis, and PSI CRO. goBalto is headquartered in San Francisco, with
offices in Philadelphia and Singapore. For more information,
visit www.gobalto.com.
For more information, please contact:
Allie Tedone/Danielle Cecchini
Diffusion PR
+1 646-571-0120
informapharma(at)diffusionpr.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Informa Business Intelligence via GlobeNewswire
Datum: 19.06.2017 - 18:45 Uhr
Sprache: Deutsch
News-ID 548660
Anzahl Zeichen: 5760
contact information:
Town:
New York
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 324 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Informa Pharma Intelligence and goBalto Partner to Enrich Clinical Trial Data for Clients"
steht unter der journalistisch-redaktionellen Verantwortung von
Informa Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
